Abiopharma

🔍 Patel Sanj K (Executive)

Company: Kiniksa Pharmaceuticals International, plc (KNSA)

Report Date: 2026-05-01

Detailed Transactions and Holdings:

• Acquired 48,565 shares of Class A Ordinary Share at $30.93 per share (Direct)
  Date: 2026-05-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 48,565.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 48,565 shares of Class A Ordinary Share at $54.02 per share (Direct)
  Date: 2026-05-01 | Code: S | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F2
• Holds 0 shares of Class A Ordinary Share (Direct)
  Date: 2026-05-01 | Code: H | nature_of_ownership: Held by The Patel Family Irrevocable Trust of 2025 | shares_owned_after: 76,174.00
• Holds 0 shares of Class A Ordinary Share (Direct)
  Date: 2026-05-01 | Code: H | nature_of_ownership: Held by The Marina 2016 Irrevocable Trust, u/d/t June 23, 2016 | shares_owned_after: 109,795.00
• Holds 0 shares of Class A Ordinary Share (Direct)
  Date: 2026-05-01 | Code: H | nature_of_ownership: Held by The Anglia 2013 Revocable Trust | shares_owned_after: 51,794.00
• Sold 48,565 shares of Share Option at $30.93 per share (Derivative)
  Date: 2026-05-01 | Code: M | Expires: 2028-09-19 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F3

Footnotes:

• F1: This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on October 31, 2025.
• F2: This transaction was executed in multiple trades through a broker-dealer at prices ranging between $54.00 and $54.155. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
• F3: The option is fully vested and exercisable.